Stocktoria
Marcus & Millichap, Inc. MMI
Marcus & Millichap, Inc. (MMI) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.73% (safety: safe). FY2025 revenue was $755.2M at a -0.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.227 |
| Retained earnings / assets | 0.495 |
| EBIT / assets | -0.017 |
| Equity / liabilities | 2.691 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MMI | Marcus & Millichap, Inc. | 4/9 | 5.82 | — | +8.5% |
| OPAD | Offerpad Solutions Inc. | 4/9 | -9.95 | — | -38.2% |
| DOUG | Douglas Elliman Inc. | 5/9 | 1.55 | 10.8 | +3.8% |
| FTHM | Fathom Holdings Inc. | 3/9 | -4.94 | — | +25.4% |
| RMAX | RE/MAX Holdings, Inc. | 6/9 | 1.72 | 40.9 | -5.2% |
| LRHC | La Rosa Holdings Corp. | 4/9 | — | — | +16.7% |
| LHAI | Linkhome Holdings Inc. | 3/9 | 7.15 | 141.1 | — |
All Finance, Insurance & Real Estate companies →
About Marcus & Millichap, Inc.
Marcus & Millichap, Inc., an investment brokerage company, provides commercial real estate investment sales, financing services, research and advisory services in the United States and Canada. The company offers research on various property types comprising multifamily, retail, office, industrial, single-tenant net lease, seniors housing, self-storage, hospitality, medical office, and manufactured housing, as well as capital markets/financing. It also operates as a financial intermediary that provides commercial real estate capital markets solutions, including senior debt, mezzanine debt, joint venture, preferred equity, and securitization services, as well as loan sales and due diligence services to commercial real estate owners, developers, and investors. In addition, the company offers a way to buy and sell commercial property as a complement to its traditional property marketing channels. Further, it provides advisory and consulting services, which include opinions of value, operating and financial performance benchmarking analysis, specific asset buy-sell strategies, market and submarket analysis and ranking, portfolio strategies by property type, market strategy, development and redevelopment feasibility studies, and other services; and leasing services for tenants and/or landlords in connection with commercial real estate leases. Marcus & Millichap, Inc. was founded in 1971 and is headquartered in Calabasas, California.
FAQ
Is MMI financially healthy?
Marcus & Millichap, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does MMI pay a dividend, and is it safe?
Yes. Marcus & Millichap, Inc. pays a dividend yielding about 1.73% with a -1076.5% payout ratio, rated “safe” for safety.
How profitable is MMI?
In FY2025, Marcus & Millichap, Inc. had a net margin of -0.3% and a return on equity of -0.3%.
Is MMI overvalued or undervalued?
Marcus & Millichap, Inc. trades at about 12.0× trailing earnings — below its 10-year norm (10-year range 13.2×–69.5×, median 18.2×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for MMI?
The average Wall-Street price target for Marcus & Millichap, Inc. is $28.00, about 10.1% below the recent price, from 1 analysts.
Is MMI a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Marcus & Millichap, Inc.: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a dividend yield of 1.73%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.